These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22229883)

  • 1. Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance.
    De Cock RF; Allegaert K; Schreuder MF; Sherwin CM; de Hoog M; van den Anker JN; Danhof M; Knibbe CA
    Clin Pharmacokinet; 2012 Feb; 51(2):105-17. PubMed ID: 22229883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does "Birth" as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full-Term Neonates by Avoiding the Creatinine Bias.
    Salem F; Johnson TN; Hodgkinson ABJ; Ogungbenro K; Rostami-Hodjegan A
    J Clin Pharmacol; 2021 Feb; 61(2):159-171. PubMed ID: 32885464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amikacin maturation model as a marker of renal maturation to predict glomerular filtration rate and vancomycin clearance in neonates.
    Zhao W; Biran V; Jacqz-Aigrain E
    Clin Pharmacokinet; 2013 Dec; 52(12):1127-34. PubMed ID: 24027065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neonatal amikacin covariate model can be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates.
    De Cock RF; Allegaert K; Sherwin CM; Nielsen EI; de Hoog M; van den Anker JN; Danhof M; Knibbe CA
    Pharm Res; 2014 Mar; 31(3):754-67. PubMed ID: 24065592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of ibuprofen or indomethacin on renal drug clearance in neonates.
    Allegaert K
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():88-91. PubMed ID: 19701859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal drug clearance in preterm neonates: relation to prenatal growth.
    Allegaert K; Anderson BJ; van den Anker JN; Vanhaesebrouck S; de Zegher F
    Ther Drug Monit; 2007 Jun; 29(3):284-91. PubMed ID: 17529884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
    Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
    Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis.
    Sherwin CM; Svahn S; Van der Linden A; Broadbent RS; Medlicott NJ; Reith DM
    Eur J Clin Pharmacol; 2009 Jul; 65(7):705-13. PubMed ID: 19305985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of glomerular filtration rate maturation across preterm and term neonates and young infants using inulin as marker.
    Wu Y; Allegaert K; Flint RB; Simons SHP; Krekels EHJ; Knibbe CAJ; Völler S
    AAPS J; 2022 Feb; 24(2):38. PubMed ID: 35212832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of ibuprofen administration on renal drug clearance in the first weeks of life.
    Allegaert K; Rayyan M; Anderson BJ
    Methods Find Exp Clin Pharmacol; 2006 Oct; 28(8):519-22. PubMed ID: 17136231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
    Smits A; De Cock RF; Allegaert K; Vanhaesebrouck S; Danhof M; Knibbe CA
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6344-51. PubMed ID: 26248375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited predictability of amikacin clearance in extreme premature neonates at birth.
    Allegaert K; Anderson BJ; Cossey V; Holford NH
    Br J Clin Pharmacol; 2006 Jan; 61(1):39-48. PubMed ID: 16390350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating renal function and age as predictors of amikacin clearance in neonates: model-based analysis and optimal dosing strategies.
    Illamola SM; Colom H; van Hasselt JG
    Br J Clin Pharmacol; 2016 Sep; 82(3):793-805. PubMed ID: 27198625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation.
    Bleyzac N; Varnier V; Labaune JM; Corvaisier S; Maire P; Jelliffe RW; Putet G; Aulagner G
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):499-504. PubMed ID: 11699615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.
    Nielsen EI; Sandström M; Honoré PH; Ewald U; Friberg LE
    Clin Pharmacokinet; 2009; 48(4):253-63. PubMed ID: 19492870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration.
    De Cock RF; Allegaert K; Brussee JM; Sherwin CM; Mulla H; de Hoog M; van den Anker JN; Danhof M; Knibbe CA
    Pharm Res; 2014 Oct; 31(10):2643-54. PubMed ID: 24789450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of gestational age and birth weight on amikacin clearance on day 1 of life.
    Schreuder MF; Wilhelm AJ; Bökenkamp A; Timmermans SM; Delemarre-van de Waal HA; van Wijk JA
    Clin J Am Soc Nephrol; 2009 Nov; 4(11):1774-8. PubMed ID: 19713296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The amikacin research program: a stepwise approach to validate dosing regimens in neonates.
    Smits A; Kulo A; van den Anker J; Allegaert K
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):157-166. PubMed ID: 27623706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A physiological approach to renal clearance: From premature neonates to adults.
    Holford N; O'Hanlon CJ; Allegaert K; Anderson B; Falcão A; Simon N; Lo YL; Thomson AH; Sherwin CM; Jacqz-Aigrain E; Llanos-Paez C; Hennig S; Mockus L; Kirkpatrick C
    Br J Clin Pharmacol; 2024 Apr; 90(4):1066-1080. PubMed ID: 38031322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.
    Li Z; Chen Y; Li Q; Cao D; Shi W; Cao Y; Wu D; Zhu Y; Wang Y; Chen C
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1223-33. PubMed ID: 23354809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.